Drawing for TUMORVISION

USPTO serial 98211160

TUMORVISION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WOLFSEN, CHRISTIANNE LISBETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TUMORVISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
042Consultancy relating to research in the field of pharmacogenetics; scientific laboratory services, namely, solvent testing services; scientific research in the field of genetic engineering; laboratory research in the field of gene expression; scientific research, namely, research in the field of gene analysis; genetic testing for scientific research purposes, namely, genetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; scientific research, namely, genetic research; genetic testing for scientific research purposes; product research, namely, research into new products; structural and functional analysis of genomesACTIVE—
044Medical services, namely, medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; medical services, namely, provision of genetic information for medical treatment purposes; medical services, namely, analysis of human biodata for medical purposes; medical services, namely, provision of genetic testing for medical treatment purposes; medical services, namely, provision of gene therapy for medical treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 29, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 2, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 20, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 20, 2025EX1GSOU EXTENSION 1 GRANTED—
Feb 19, 2025EXT1SOU EXTENSION 1 FILED—
Feb 19, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 14, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 12, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2024DOCKASSIGNED TO EXAMINER—
Oct 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance